Zafer Arik
Ankara, 06100, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
Outcomes of First-Line PARP Inhibitor Therapy in Ovarian Cancer: A Multicenter Retrospective Analysis.
Journal: Journal of clinical medicine
Published: February 01, 2026
Lenvatinib plus pembrolizumab in previously treated advanced endometrial cancer: 5-year outcomes from the randomized, phase 3 Study 309/KEYNOTE-775.
Journal: Journal for immunotherapy of cancer
Published: January 20, 2026
Prognostic Impact of Pre-Treatment Modified Glasgow Prognostic Score (mGPS) on Survival in Patients with Advanced-Stage Ovarian Cancer.
Journal: Journal of clinical medicine
Published: May 10, 2025
Adjuvant radiotherapy outcomes and prognostic factors in FIGO 2023 stage IIC endometrial cancer: One sea, different depths.
Journal: Gynecologic oncology
Published: March 14, 2025
The association between blood sodium levels and survival in patients treated with immune checkpoint inhibitors.
Journal: Expert review of molecular diagnostics
Published: February 26, 2025
The association between HALP score and survival in patients treated with immune checkpoint inhibitors.
Journal: Expert review of anticancer therapy
Published: January 08, 2025
Efficacy of cumulative cisplatin dose on survival in patients with locally advanced cervical cancer treated with definitive chemoradiotherapy: multicenter study by Turkish Oncology Group.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: July 01, 2024
The predictive role of PD-L1 expression and CD8 + TIL levels in determining the neoadjuvant chemotherapy response in advanced ovarian cancer.
Journal: Journal of ovarian research
Published: March 09, 2024
Efficacy and safety of bevacizumab in patients with low-grade serous ovarian cancer.
Journal: Future oncology (London, England)
Published: February 08, 2024
Effect of hypoxia-inducible factor-1 alpha expression on survival in patients with metastatic cervical squamous cell carcinoma treated with first-line chemotherapy and bevacizumab.
Journal: Biomolecules & biomedicine
Published: January 07, 2024
KELIM score predicts outcome in patients with platinum-resistant/refractory recurrent ovarian cancer.
Journal: Biomarkers in medicine
Published: June 13, 2023
Last Updated: 09/26/2026